# Junta clínica — PT-pseudo_62c93b0c3dba (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_62c93b0c3dba",
  "pid": "PT-pseudo_62c93b0c3dba",
  "task": 1,
  "psa": 7.9,
  "age": 67,
  "months": 2,
  "pirads": "5",
  "psad": 0.181,
  "psav": 1.38,
  "psap": 10.0,
  "vol": 43.67,
  "dre": "Not done",
  "bx": "None",
  "cspca": 0.86869615,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 7.9 ng/mL. PI-RADS 5. PSAD 0.18. Prostate volume 44 mL. csPCa 0.87.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "87 kg",
    "height": "182 cm",
    "bmi": "26.3",
    "bp": "100/76 mmHg",
    "hr": "79 bpm",
    "smoking": "Non-smoker",
    "last_dental": "6 mo ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "26 Jan 2025",
  "enc_ref": "Dr. N. Kuiper (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "The patient seeks evaluation due to ascending PSA readings and newly acquired multiparametric MRI results."
    },
    {
      "s": "History",
      "t": "Mr X, a 67-year-old retired firefighter, arrived for dedicated urology review after his PSA climbed steadily over the last three years. He describes moderate lower urinary tract symptoms aligning with an IPSS score of 16, characterized mainly by frequent nighttime urination and a diminished flow, yet he denies pelvic discomfort or blood in the urine. Socially, he remains married but occupies a residence by himself; his adult daughter serves as his main point of contact, while his wife holds next-of-kin status. He logs roughly 14 units of alcohol each week and keeps a mostly inactive lifestyle, broken only by sporadic strolls. Beyond his urological issues, a recent audiology check uncovered mild hearing loss in both ears, and he manages longstanding, stable osteoarthritis in his right knee using paracetamol. He has zero known drug allergies, consumes no daily prescriptions, and avoids tobacco entirely. An Arabic interpreter has been secured for his next appointment to guarantee accurate dialogue."
    },
    {
      "s": "Physical examination",
      "t": "DRE: Omitted entirely due to scheduling limitations and the patient’s stated preference. Overall inspection shows a well-built individual in stable condition. Lung fields are clear, heart rhythm regular, and vitals remain steady (blood pressure 100/76 mmHg, heart rate 79 bpm). The abdomen yields to gentle palpation without tenderness, masses, or organ enlargement."
    }
  ],
  "occupation": "retired firefighter",
  "marital": "Married",
  "living": "Lives alone; adult daughter is primary contact",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Audiology — hearing test"
  ],
  "alcohol": "14 units / week",
  "exercise": "Sedentary lifestyle, occasional walking",
  "ipss": "IPSS score: 16/35 (moderate LUTS)",
  "admin": "Interpreter (Arabic) requested for next visit.",
  "mri_hospital": "Amsterdam UMC (location AMC)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_62c93b0c3dba
Task: 1

Encounter: Urology - outpatient on 26 Jan 2025.
Referrer: Dr. N. Kuiper (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 67-year-old male
  - PSA: 7.9 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.181 ng/mL²
  - PSA velocity: 1.38 ng/mL/yr
  - Prior PSA: 10.0 ng/mL
  - Prostate volume: 43.67 mL
  - Months since last PSA: 2
  - DRE findings: Not done (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.86869615 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 7.9 ng/mL. PI-RADS 5. PSAD 0.18. Prostate volume 44 mL. csPCa 0.87.

Vitals: weight 87 kg, height 182 cm, BMI 26.3, BP 100/76 mmHg, HR 79 bpm. Smoking: Non-smoker.

Chief complaint: The patient seeks evaluation due to ascending PSA readings and newly acquired multiparametric MRI results.

History: Mr X, a 67-year-old retired firefighter, arrived for dedicated urology review after his PSA climbed steadily over the last three years. He describes moderate lower urinary tract symptoms aligning with an IPSS score of 16, characterized mainly by frequent nighttime urination and a diminished flow, yet he denies pelvic discomfort or blood in the urine. Socially, he remains married but occupies a residence by himself; his adult daughter serves as his main point of contact, while his wife holds next-of-kin status. He logs roughly 14 units of alcohol each week and keeps a mostly inactive lifestyle, broken only by sporadic strolls. Beyond his urological issues, a recent audiology check uncovered mild hearing loss in both ears, and he manages longstanding, stable osteoarthritis in his right knee using paracetamol. He has zero known drug allergies, consumes no daily prescriptions, and avoids tobacco entirely. An Arabic interpreter has been secured for his next appointment to guarantee accurate dialogue.

Physical examination: DRE: Omitted entirely due to scheduling limitations and the patient’s stated preference. Overall inspection shows a well-built individual in stable condition. Lung fields are clear, heart rhythm regular, and vitals remain steady (blood pressure 100/76 mmHg, heart rate 79 bpm). The abdomen yields to gentle palpation without tenderness, masses, or organ enlargement.

Patient info: retired firefighter; Married; Lives alone; adult daughter is primary contact.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 14 units / week; exercise Sedentary lifestyle, occasional walking; IPSS score: 16/35 (moderate LUTS).

Recent other appointments: Audiology — hearing test.
Admin: Interpreter (Arabic) requested for next visit.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.85
  uncertainty  +/- 0.05 epistemic (95% band 0.75-0.95); among patients I cannot tell apart the outcome was 0.61 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = none recorded (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 67 (2% of my signal; from age) · DRE = Not done (10% of my signal; from dre_suspicious) · PSA = 7.9 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 43.67 mL (1% of my signal; from log_vol, vol) · PSA density = 0.181 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.87 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 5
  important  prior biopsy = None
  noted      age = 67 · DRE = Not done · PSA = 7.9 ng/mL · prostate volume = 43.67 mL · PSA density = 0.181 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: clear — the rule matched the reading urologist in 24 of 24 labelled cases

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 24 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.09: PI-RADS 5, PSA 5.5, PSAD 0.136, age 61, DRE Normal -> BIOPSY (clear). He wrote: "Biopsy naive PIRADS 5 needs biopsy"
  2. distance 1.22: PI-RADS 5, PSA 5.9, PSAD 0.199, age 60, DRE Normal -> BIOPSY (clear). He wrote: "PIRADS 5 in a 60 year old man"
  3. distance 1.22: PI-RADS 5, PSA 7.0, PSAD 0.329, age 63, DRE Normal -> BIOPSY (clear). He wrote: "P5 in a man with rapid increasing PSA"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 5
  important  age = 67 · PSA = 7.9 ng/mL
  noted      prior biopsy = None · DRE = Not done · prostate volume = 43.67 mL · PSA density = 0.181 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: clear — the precedents agree (1.00) and the library is right 92% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 24 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   PI-RADS = 5
  important  age = 67 · PSA = 7.9 ng/mL
  noted      prior biopsy = None · family history = not opened (0 of 91) · DRE = Not done · prostate volume = 43.67 mL · PSA density = 0.181 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guideline discusses using the PI-RADS score to trigger biopsy, stating, "a PI-RADS threshold of $\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]." This requires a decision based on the PI-RADS score.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of BIOPSY p(biopsy) = 0.85 is high, but the guideline treats the PI-RADS score as the primary trigger. The guideline suggests that a PI-RADS $\ge 3$ mandates a biopsy, which is what EXPERT-COHORT confirms. The guideline makes the PI-RADS score decisive, whereas EXPERT-STRUCTURED marked prior biopsy = None as decisive. The guideline suggests that the PI-RADS score is the key variable, whereas EXPERT-STRUCTURED weighted prior biopsy = None as decisive. The guideline requires the PI-RADS score, which is already known, whereas EXPERT-STRUCTURED weighted prior biopsy = None as decisive. The guideline requires the PI-RADS score, which is already known, whereas EXPERT-STRUCTURED weighted prior biopsy = None as decisive. The guideline requires the PI-RADS score, which is already known, whereas EXPERT-STRUCTURED weighted prior biopsy = None as decisive.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy: at None the guideline suggests biopsy is triggered by PI-RADS $\ge 3$, not the prior biopsy status alone; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trend: the guideline does not explicitly state how the PSA trend interacts with the PI-RADS score for biopsy indication; if it is unrecorded the indication stands
laboratory_results - the laboratory results: the guideline links PSA density to risk stratification, suggesting that a PSA density $< 0.10 \text{ ng/mL/cc}$ and no family history might lead to omitting biopsy if MRI is negative.
family-history anamnesis - the family history of prostate cancer: the guideline notes that the prevalence of csPCa is a factor in risk stratification, which is a variable the guideline treats as context, not a primary decision point.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges on whether the PI-RADS 5 score alone, as per the EAU guideline, is sufficient to mandate biopsy, or if the lack of prior biopsy status is the decisive factor.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the mpMRI prose indicate whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> Does the PSA trend interact with the PI-RADS score for biopsy indication?
  previous_notes (get_previous_notes) -> What is the GRADE of the prior biopsy, and is the patient on a surveillance protocol?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the GRADE of the prior biopsy, as detailed in the previous notes?

On the plan itself: Dropped 1 question(s) that asked for a value already printed on the panel: "What should be done given the PI-RADS = 5, according to the EAU guideline?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The mpMRI prose indicates that the lesion is compared against an earlier study: "PSA value: 7.9 ng/mL alongside routine monitoring."
psa_trend
The PSA trend does not explicitly state how the PSA trend interacts with the PI-RADS score for biopsy indication.
previous_notes
The GRADE of the prior biopsy is "None", and the patient is not on a surveillance protocol.

WHAT I DID NOT OPEN
laboratory_results, family-history anamnesis, and the full panel were not opened because they were not explicitly requested by the plan or necessary to answer the immediate open questions.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS = 5, as confirmed by EXPERT-COHORT and EXPERT-LIBRARY, which aligns with the EAU guideline trigger.
Prior biopsy = None, as noted by EXPERT-STRUCTURED and EXPERT-COHORT, suggesting a need for sampling when the MRI is high risk.
PSA = 7.9 ng/mL, as noted by EXPERT-STRUCTURED and EXPERT-TRACE, indicating a high PSA level.

AGAINST sampling this patient now
laboratory_results
The guideline suggests that a PSA density $< 0.10 \text{ ng/mL/cc}$ and no family history might lead to omitting biopsy if MRI is negative.

WHERE THIS LEANS
The PI-RADS 5 score strongly supports biopsy according to the EAU guideline, despite the lack of prior biopsy status.
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.90 ng/mL over 5 points spanning 29 months; velocity +2.57 ng/mL per year; doubling time about 12 months.
PROJECTION at 6 months: 11.8 ng/mL, conformal 95% band 3.4-41.0.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 7.9 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.73
  uncertainty  +/- 0.08 epistemic (95% band 0.58-0.89), of which 0.01 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 7.9 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 43.67 mL (4% of my signal; from log_vol, vol) · PSA density = 0.181 (0% of my signal; from psad_calc) · comorbidity = none recorded (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.85  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.73  ('firm' tier, fusion_nolab; weight 4.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           None                         E1:DEC E3:DEC cohort:IMP library:not E2:—            -> noted
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:— E2:—                    -> not_used (raised from noted by the board)
  age          67                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Not done                     E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          7.9 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          43.67 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.181                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.87                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:DEC library:DEC E2:—            -> decisive
  comorbidity  none recorded                E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) answered the moderator's questions. The registrar reported that the GRADE of the prior biopsy is "None" from the previous notes.

ALIGNMENT WITH THE PANEL
The retrieved evidence aligns with the PANEL-PROTOCOL's answer of BIOPSY. The cohort criterion (PI-RADS $\ge 3$) fired, and the registrar confirmed the prior biopsy status as "None," which supports the panel's conclusion.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the GRADE of the prior biopsy, as detailed in the previous notes? This was answered by the Registrar, who reported the GRADE as "None."

WHAT CARRIES WEIGHT, AND WHY
<pirads>: decisive: 5 (The PI-RADS 5 score was decisive as per EXPERT-COHORT and EXPERT-LIBRARY, aligning with the EAU guideline trigger.)
<prior biopsy>: decisive: None (The lack of a prior biopsy was decisive as per EXPERT-STRUCTURED and EXPERT-COHORT, supporting the need for sampling.)
<psa>: important: 7.9 ng/mL (The PSA level was important as noted by multiple experts, reflecting the clinical context.)
My confidence in the record as it stands is clear, as all necessary variables for the panel's decision were retrieved.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy based on the strong alignment between the PI-RADS 5 score and the panel protocol, which was supported by the retrieved finding that the prior biopsy was "None."

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

67 y/o male, PSA 7.9 ng/mL, PI-RADS 5, biopsy-naive. PI-RADS 5 mandates biopsy, supported by the PSA density of 0.181. No prior pathology to contraindicate sampling.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
